VKTX: Viking Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,628.37
Enterprise Value ($M) 3,578.02
Book Value ($M) 911.45
Book Value / Share 8.18
Price / Book 3.98
NCAV ($M) 910.21
NCAV / Share 8.17
Price / NCAV 3.99

Profitability (mra)
Return on Invested Capital (ROIC) -0.11
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.28

Liquidity (mrq)
Quick Ratio 36.47
Current Ratio 36.47

Balance Sheet (mrq) ($M)
Current Assets 936.65
Assets 937.89
Liabilities 26.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Viking Global Investors Lp 0.60 -85.97
11-12 13G/A Vanguard Group Inc 9.17 0.00
10-18 13G/A State Street Corp 4.20 -18.61
08-07 13G/A BlackRock, Inc. 4.90 -28.16
02-09 13G/A Fmr Llc 15.00 37.37
2024-01-12 13G/A Millennium Management Llc 0.40 -91.64

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-23 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-07-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-17 948,004 3,956,048 23.96
2025-01-16 693,167 4,733,388 14.64
2025-01-15 417,135 3,635,968 11.47
2025-01-14 960,612 7,374,564 13.03
2025-01-13 586,536 2,991,176 19.61

(click for more detail)

Similar Companies
VERU – Veru Inc. VINC – Vincerx Pharma, Inc.
VIRX – Viracta Therapeutics, Inc. VRPX – Virpax Pharmaceuticals, Inc.
VSTM – Verastem, Inc.


Financial data and stock pages provided by
Fintel.io